Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Peptic Ulcer

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 96 articles:
HTML format



Single Articles


    June 2021
  1. TAKIMOTO M, Tomita T, Yamasaki T, Fukui S, et al
    Correction to: Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the (13)C-Urea Breath Test in Helicobacter pylori-Positive Patients.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07090.
    PubMed    


    May 2021
  2. CHANG YW, Shin GY, Kim JW, Moon JC, et al
    Correction to: CostEffectiveness of Empirical BismuthBased Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 May 20. pii: 10.1007/s10620-021-07061.
    PubMed    


  3. SAKAE H, Kanzaki H, Satomi T, Okanoue S, et al
    Linked Color Imaging (LCI) Emphasizes the Color Changes in the Gastric Mucosa After Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07030.
    PubMed     Abstract available


  4. MUTHA PR, Fasullo M, Chu S, Schubert ML, et al
    Correlation of Probe-Based Confocal Laser Endomicroscopy (pCLE) and Mucosal Integrity Testing (MIT) with Epithelial Barrier Function and Presence of Gastroesophageal Reflux Disease (GERD).
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06980.
    PubMed     Abstract available


  5. WEISSMAN S, Sharma S, Aziz M, Ehrlich D, et al
    Impact of Readmission for Variceal Upper Gastrointestinal Bleeding: A Nationwide Analysis.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-07011.
    PubMed     Abstract available


    April 2021
  6. KUMAR S, Goldberg DS, Kaplan DE
    Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
    Dig Dis Sci. 2021 Apr 15. pii: 10.1007/s10620-021-06972.
    PubMed     Abstract available


    March 2021
  7. CHANG YW, Shin GY, Kim JW, Moon JC, et al
    Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06938.
    PubMed     Abstract available


  8. BLACKETT JW, Chen L, Li J, Wright JD, et al
    Inappropriateness of Proton Pump Inhibitors After Hospital Discharge Is Associated with Thirty-Day Hospital Readmission.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06909.
    PubMed     Abstract available


  9. EL-DALLAL M, Walradt TJ, Stein DJ, Khrucharoen U, et al
    Pros and Cons of Performing Early Endoscopy in Geriatric Patients Admitted with Non-variceal Upper Gastrointestinal Bleeding: Analysis of the US National Inpatient Database.
    Dig Dis Sci. 2021 Mar 12. pii: 10.1007/s10620-021-06924.
    PubMed     Abstract available


    February 2021
  10. HE XJ, Zeng XP, Jiang CS, Liu G, et al
    Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06856.
    PubMed     Abstract available


  11. WEITSMAN S, Celly S, Leite G, Mathur R, et al
    Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06857.
    PubMed     Abstract available


    January 2021
  12. HARRIS DM, Stancampiano FF, Burton MC, Moyer AM, et al
    Use of Pharmacogenomics to Guide Proton Pump Inhibitor Therapy in Clinical Practice.
    Dig Dis Sci. 2021 Jan 21. pii: 10.1007/s10620-020-06814.
    PubMed     Abstract available


  13. KOWADA A
    Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Dig Dis Sci. 2021 Jan 8. pii: 10.1007/s10620-020-06813.
    PubMed     Abstract available


    October 2020
  14. AL-TAEE AM, Ghoulam E, Lee P, Edwards M, et al
    Underutilization of Peptic Ulcer Disease Prophylaxis Among Elderly Users of Antiplatelets and Anticoagulants.
    Dig Dis Sci. 2020 Oct 21. pii: 10.1007/s10620-020-06665.
    PubMed     Abstract available


    September 2020
  15. ALEXANDER R, Alexander JA, Akambase J, Harmsen WS, et al
    Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis: Predictors of Nonresponse.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06633.
    PubMed     Abstract available


  16. ABBASS A, Khalid S, Boppana V, Hanson J, et al
    Giant Gastric Ulcers: An Unusual Culprit.
    Dig Dis Sci. 2020 Sep 2. pii: 10.1007/s10620-020-06573.
    PubMed     Abstract available


    June 2020
  17. YUE W, Liu Y, Jiang W, Huang J, et al
    Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
    PubMed     Abstract available


  18. TOSETTI C, Savarino E, Benedetto E, De Bastiani R, et al
    Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06414.
    PubMed     Abstract available


  19. OSHIMA T, Miwa H
    How Does Vonoprazan Affect the Treatment of Erosive Esophagitis?
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06387.
    PubMed    


    April 2020
  20. KOUITCHEU MABEKU LB, Bello Epesse M, Fotsing S, Kamgang R, et al
    Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06219.
    PubMed     Abstract available


  21. PIOPPO L, Bhurwal A, Reja D, Tawadros A, et al
    Incidence of Non-variceal Upper Gastrointestinal Bleeding Worsens Outcomes with Acute Coronary Syndrome: Result of a National Cohort.
    Dig Dis Sci. 2020 Apr 23. pii: 10.1007/s10620-020-06266.
    PubMed     Abstract available


    March 2020
  22. GUEVARA B, Cogdill AG
    Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06193.
    PubMed     Abstract available


  23. SATOH H, Akiba Y, Urushidani T
    Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice.
    Dig Dis Sci. 2020 Mar 5. pii: 10.1007/s10620-020-06157.
    PubMed     Abstract available


    February 2020
  24. CHENG Y, Liu J, Tan X, Dai Y, et al
    Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Feb 24. pii: 10.1007/s10620-020-06141.
    PubMed     Abstract available


  25. OSMAN A, Albashir MM, Nandipati K, Walters RW, et al
    Esophagogastric Junction Morphology on Hill's Classification Predicts Gastroesophageal Reflux with Good Accuracy and Consistency.
    Dig Dis Sci. 2020 Feb 20. pii: 10.1007/s10620-020-06146.
    PubMed     Abstract available


  26. LUO L, Ji Y, Yu L, Huang Y, et al
    14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
    Dig Dis Sci. 2020 Feb 4. pii: 10.1007/s10620-020-06115.
    PubMed     Abstract available


    January 2020
  27. NAM SY, Lee SW, Jeon SW, Kwon YH, et al
    Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06065.
    PubMed     Abstract available


  28. BI D, Katzka DA, Lavey CJ, Geno DM, et al
    Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients.
    Dig Dis Sci. 2020 Jan 6. pii: 10.1007/s10620-019-06027.
    PubMed     Abstract available


  29. MATTHIS AL, Kaji I, Engevik KA, Akiba Y, et al
    Deficient Active Transport Activity in Healing Mucosa After Mild Gastric Epithelial Damage.
    Dig Dis Sci. 2020;65:119-131.
    PubMed     Abstract available


    November 2019
  30. NGUYEN TH, Mallepally N, Hammad T, Liu Y, et al
    Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population.
    Dig Dis Sci. 2019 Nov 14. pii: 10.1007/s10620-019-05955.
    PubMed     Abstract available


  31. LEVY AN, Ali N, Andrici J, Hamilton MJ, et al
    It's What's Up Front That Counts-Part Two: Esophageal Crohn's Disease Complicated by Recurrent Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05922.
    PubMed    


    October 2019
  32. HAN Y, Yan T, Ma H, Yao X, et al
    Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05910.
    PubMed     Abstract available


  33. LEJA M, Dumpis U
    What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05893.
    PubMed     Abstract available


    August 2019
  34. PAPAMICHAEL K, Papaioannou G, Cheifetz MA, Cheifetz AS, et al
    Bone of Contention: Helicobacter pylori and Osteoporosis-Is There an Association?
    Dig Dis Sci. 2019 Aug 12. pii: 10.1007/s10620-019-05775.
    PubMed     Abstract available


  35. MANSILLA-VIVAR R, Serrano CA, Palma C, Vera M, et al
    High Helicobacter pylori Bacterial Load and Low Cytokine Expression Levels Are Associated with Nodular Gastropathy.
    Dig Dis Sci. 2019 Aug 7. pii: 10.1007/s10620-019-05769.
    PubMed     Abstract available


  36. HASHIMOTO A, Uemura R, Sawada A, Nadatani Y, et al
    Changes in Clock Genes Expression in Esophagus in Rat Reflux Esophagitis.
    Dig Dis Sci. 2019;64:2132-2139.
    PubMed     Abstract available


    July 2019
  37. TAO J, Li J, Chen X, Guo Y, et al
    Endoscopic Variceal Sequential Ligation Does Not Increase Risk of Gastroesophageal Reflux Disease in Cirrhosis Patients.
    Dig Dis Sci. 2019 Jul 22. pii: 10.1007/s10620-019-05740.
    PubMed     Abstract available


  38. YADLAPATI R, Gupta S, Pandolfino JE
    Do Vigorous Esophageal Contractions Contribute to Rigorous Phenotyping of Gastroesophageal Reflux Disease?
    Dig Dis Sci. 2019 Jul 4. pii: 10.1007/s10620-019-05711.
    PubMed    


    June 2019
  39. ALSAMMAN MA, Vecchio EC, Shawwa K, Acosta-Gonzales G, et al
    Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05694.
    PubMed     Abstract available


    April 2019
  40. NAKATAKE R, Hishikawa H, Kotsuka M, Ishizaki M, et al
    The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05622.
    PubMed     Abstract available


    March 2019
  41. LIM SH, Kim N, Kwon JW, Kim SE, et al
    Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05544.
    PubMed     Abstract available


  42. YAMASHITA H, Okada A, Naora K, Hongoh M, et al
    Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Dig Dis Sci. 2019;64:823-831.
    PubMed     Abstract available


    February 2019
  43. SAKURAI K, Suda H, Fujie S, Takeichi T, et al
    Correction to: Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-5464.
    PubMed     Abstract available


    January 2019
  44. SHI S, Lin Y, Ding R, Chen Y, et al
    Preventive Effects of Epinephrine for Critically Ill Patients? More Questions Waiting to Be Answered.
    Dig Dis Sci. 2019;64:283-284.
    PubMed    


    November 2018
  45. PONZETTO A, Holton J
    Risk of Rebleeding After Hemostasis for Peptic Ulcer.
    Dig Dis Sci. 2018 Nov 16. pii: 10.1007/s10620-018-5375.
    PubMed    


  46. SAKURAI K, Suda H, Fujie S, Takeichi T, et al
    Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan.
    Dig Dis Sci. 2018 Nov 10. pii: 10.1007/s10620-018-5365.
    PubMed     Abstract available


  47. GREMSE D, Gold BD, Pilmer B, Hunt B, et al
    Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents.
    Dig Dis Sci. 2018 Nov 2. pii: 10.1007/s10620-018-5325.
    PubMed     Abstract available


    October 2018
  48. BECQ A, Urien S, Barret M, Faisy C, et al
    Epinephrine Dose Has a Preventive Effect on the Occurrence of Stress Ulcer-Induced Gastrointestinal Bleeding in Critically Ill Patients.
    Dig Dis Sci. 2018;63:2687-2694.
    PubMed     Abstract available


    September 2018
  49. DONG T, Pisegna J
    Passing the "Acid Test": Do Proton Pump Inhibitors Affect the Composition of the Microbiome?
    Dig Dis Sci. 2018 Sep 14. pii: 10.1007/s10620-018-5273.
    PubMed    


  50. OKWARA CJ, Gulati R, Rustagi T, Birg A, et al
    Upper Gastrointestinal Bleeding of Unusual Causation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5260.
    PubMed    


    August 2018
  51. PARK HW, Jeon SW
    Clinical Outcomes of Patients with Non-ulcer and Non-variceal Upper Gastrointestinal Bleeding: A Prospective Multicenter Study of Risk Prediction Using a Scoring System.
    Dig Dis Sci. 2018 Aug 21. pii: 10.1007/s10620-018-5255.
    PubMed     Abstract available


  52. WAGHRAY A, Waghray N, Perzynski AT, Votruba M, et al
    Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5235.
    PubMed     Abstract available


  53. ALVAREZ MC, Fernandes J, Michel V, Touati E, et al
    Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients.
    Dig Dis Sci. 2018 Aug 6. pii: 10.1007/s10620-018-5223.
    PubMed     Abstract available


    July 2018
  54. BANG BW, Lee DH, Kim HK, Kwon KS, et al
    CEGP-003 Spray Has a Similar Hemostatic Effect to Epinephrine Injection in Cases of Acute Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2018 Jul 27. pii: 10.1007/s10620-018-5208.
    PubMed     Abstract available


  55. KONDO Y, Hatta W, Koike T, Takahashi Y, et al
    The Use of Higher Dose Steroids Increases the Risk of Rebleeding After Endoscopic Hemostasis for Peptic Ulcer Bleeding.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5209.
    PubMed     Abstract available


  56. VAKHSHOORI M, Keshteli AH, Saneei P, Esmaillzadeh A, et al
    Relationship Between Meal Frequency and Gastroesophageal Reflux Disease (GERD) in Iranian Adults.
    Dig Dis Sci. 2018 Jul 16. pii: 10.1007/s10620-018-5200.
    PubMed     Abstract available


  57. BOGNAR L, Vereczkei A, Papp A, Jancso G, et al
    Gastroesophageal Reflux Disease Might Induce Certain-Supposedly Adaptive-Changes in the Esophagus: A Hypothesis.
    Dig Dis Sci. 2018 Jul 11. pii: 10.1007/s10620-018-5184.
    PubMed     Abstract available


  58. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed    


    June 2018
  59. TRIADAFILOPOULOS G, Zikos T, Regalia K, Sonu I, et al
    Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Dig Dis Sci. 2018 Jun 29. pii: 10.1007/s10620-018-5183.
    PubMed     Abstract available


  60. TUMGOR G, Agin M, Doran F, Cetiner S, et al
    Frequency of Celiac Disease in Children with Peptic Ulcers.
    Dig Dis Sci. 2018 Jun 26. pii: 10.1007/s10620-018-5174.
    PubMed     Abstract available


    May 2018
  61. HOJO M, Asahara T, Nagahara A, Takeda T, et al
    Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.
    Dig Dis Sci. 2018 May 24. pii: 10.1007/s10620-018-5122.
    PubMed     Abstract available


    March 2018
  62. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    PubMed    


  63. CALABRESE C, Salice M
    Revenge of the NERDs: Cadherin Fragments Differentiate Functional Heartburn from Non-erosive Reflux Disease.
    Dig Dis Sci. 2018;63:547-548.
    PubMed    


    February 2018
  64. HIRAI A, Takeuchi T, Takahashi Y, Kawaguchi S, et al
    Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4948.
    PubMed     Abstract available


  65. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed    


  66. YING KM, Chen Z, Dang CX, Sun MC, et al
    Clinicopathology and Survival in Patients with Gastroesophageal Reflux After Radical Surgery of Proximal Gastric Cancer.
    Dig Dis Sci. 2018 Feb 3. pii: 10.1007/s10620-018-4960.
    PubMed     Abstract available


  67. KAVITT RT, Vaezi MF
    Concise Commentary: Breathing New Life into Antisecretory Medications.
    Dig Dis Sci. 2018;63:411.
    PubMed    


  68. TORIHATA Y, Asanuma K, Iijima K, Mikami T, et al
    Estrogen-Dependent Nrf2 Expression Protects Against Reflux-Induced Esophagitis.
    Dig Dis Sci. 2018;63:345-355.
    PubMed     Abstract available


  69. YANG X, Li Y, Sun Y, Zhang M, et al
    Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Dig Dis Sci. 2018;63:302-311.
    PubMed     Abstract available


    January 2018
  70. YASUTOMI E, Hoshi N, Adachi S, Otsuka T, et al
    Proton Pump Inhibitors Increase the Susceptibility of Mice to Oral Infection with Enteropathogenic Bacteria.
    Dig Dis Sci. 2018 Jan 11. pii: 10.1007/s10620-017-4905.
    PubMed     Abstract available


  71. MASUDA T, Yano F, Omura N, Tsuboi K, et al
    Effect of Low-Dose Aspirin on Chronic Acid Reflux Esophagitis in Rats.
    Dig Dis Sci. 2018;63:72-80.
    PubMed     Abstract available


    December 2017
  72. TAN B, Yang JC, Young CL, Bishu S, et al
    Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience.
    Dig Dis Sci. 2017 Dec 20. pii: 10.1007/s10620-017-4880.
    PubMed     Abstract available


  73. YANG HJ, Chang Y, Park SK, Jung YS, et al
    Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Dig Dis Sci. 2017;62:3605-3613.
    PubMed     Abstract available


    November 2017
  74. WIJARNPREECHA K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, et al
    Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4834.
    PubMed     Abstract available


  75. KUNG YM, Hsu WH, Wu MC, Wang JW, et al
    Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2017 Nov 6. doi: 10.1007/s10620-017-4830.
    PubMed     Abstract available


  76. LO WK, Goldberg HJ, Boukedes S, Burakoff R, et al
    Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation.
    Dig Dis Sci. 2017 Nov 1. doi: 10.1007/s10620-017-4827.
    PubMed     Abstract available


    September 2017
  77. TRIADAFILOPOULOS G, Lewis D
    Expose: Different Faces of a Bleeding Giant Duodenal Ulcer.
    Dig Dis Sci. 2017 Sep 4. doi: 10.1007/s10620-017-4736.
    PubMed    


  78. MENDELSON AH, Donowitz M
    Catching the Zebra: Clinical Pearls and Pitfalls for the Successful Diagnosis of Zollinger-Ellison Syndrome.
    Dig Dis Sci. 2017;62:2258-2265.
    PubMed     Abstract available


    August 2017
  79. WIJARNPREECHA K, Thongprayoon C, Chesdachai S, Panjawatanana P, et al
    Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4725.
    PubMed     Abstract available


  80. KIM EH, Park CH
    Vonoprazan-Based Helicobacter pylori Eradication Therapy: Time to Get Kompetitive?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4699.
    PubMed    


    July 2017
  81. TAHARA T, Tahara S, Tuskamoto T, Horiguchi N, et al
    Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk.
    Dig Dis Sci. 2017 Jul 12. doi: 10.1007/s10620-017-4676.
    PubMed     Abstract available


    June 2017
  82. TANABE H, Ando K, Sato K, Ito T, et al
    Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
    Dig Dis Sci. 2017 Jun 29. doi: 10.1007/s10620-017-4664.
    PubMed     Abstract available


    April 2017
  83. FU W, Song Z, Zhou L, Xue Y, et al
    Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4564.
    PubMed     Abstract available


  84. BARTELS LE, Dahlerup JF
    Association of Helicobacter pylori and Crohn's Disease Incidence: An Inversion Reaction?
    Dig Dis Sci. 2017 Apr 5. doi: 10.1007/s10620-017-4561.
    PubMed    


  85. SUZUKI H
    Helicobacter pylori-Associated Upper Gastrointestinal Symptoms: FD or HpD?
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4556.
    PubMed    


    March 2017
  86. HU Y, Zhu Y, Lu NH
    Primary Antibiotic Resistance of Helicobacter pylori in China.
    Dig Dis Sci. 2017 Mar 17. doi: 10.1007/s10620-017-4536.
    PubMed     Abstract available


  87. LEE SP, Lee SY, Kim JH, Sung IK, et al
    Factors Related to Upper Gastrointestinal Symptom Generation in 2275 Helicobacter pylori Seroprevalent Adults.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4529.
    PubMed     Abstract available


  88. ZE EY, Kim BJ, Kang H, Kim JG, et al
    Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4467.
    PubMed     Abstract available


  89. WIJARNPREECHA K, Thongprayoon C, Nissaisorakarn P, Jaruvongvanich V, et al
    Association of Helicobacter pylori with Chronic Kidney Diseases: A Meta-Analysis.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4516.
    PubMed     Abstract available


    January 2017
  90. HSU CS, Wen SH, Hung JS, Liu TT, et al
    Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
    Dig Dis Sci. 2017 Jan 23. doi: 10.1007/s10620-017-4455.
    PubMed     Abstract available


  91. FULLER G, Bolus R, Whitman C, Talley J, et al
    PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2017 Jan 23. doi: 10.1007/s10620-016-4440.
    PubMed     Abstract available


  92. TAKIMOTO M, Tomita T, Yamasaki T, Fukui S, et al
    Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the 13C-Urea Breath Test in Helicobacter pylori-Positive Patients.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4439.
    PubMed     Abstract available


    December 2016
  93. YADLAPATI R, Dakhoul L, Pandolfino JE, Keswani RN, et al
    The Quality of Care for Gastroesophageal Reflux Disease.
    Dig Dis Sci. 2016 Dec 27. doi: 10.1007/s10620-016-4409.
    PubMed     Abstract available


    October 2016
  94. BRAR TS, Draganov PV, Yang D
    Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  95. LEE SP, Sung IK, Kim JH, Lee SY, et al
    The Clinical Features and Predisposing Factors of Asymptomatic Erosive Esophagitis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    September 2016
  96. MATSUMOTO H, Shiotani A, Katsumata R, Fujita M, et al
    Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: